Tag: officer

ORMOND BEACH, Fla., June 12, 2026 (GLOBE NEWSWIRE) -- PlanetBids today announced that it has been named to Inc.’s 2026 Best Workplaces list for the second straight year. Each year, Inc. Magazine honors American companies that have built exceptional workplaces and vibrant cultures that support their teams and businesses, whether in-person, remote, or hybrid.

Inc. evaluates and measures applicants on elements such as management effectiveness, perks, professional development, and overall company culture. A detailed employee survey conducted over a period of March 4 to March 13, 2026 and a study of each company’s benefits over a period of November 2025 to February 2026, both conducted by Quantum Workplace, determine a company’s overall score. PlanetBids is honored to be included among the 507 companies recognized this year.

Founded in 2000, PlanetBids has been a fully remote/hybrid-optional company since 2020, with offices in Studio City, Calif. and Ormond Beach, Fla. and team members located across 19 states. The company was acquired by Capstreet, a Houston-based private equity firm, from co-founders Arpie and Alan Zavian, in October 2023.

"Being recognized by Inc. as one of the Best Workplaces for the second consecutive year is an incredible honor and a reflection of what makes PlanetBids truly special: our people," says David DiGiacomo, Chief Executive Officer at PlanetBids. "As a primarily remote company, we believe we’re proving that culture isn’t built by sharing an office; it’s built by sharing a mission, values, trust, and a commitment to each other’s success. This recognition belongs to every member of our team who shows up each day with passion, curiosity, and a desire to make a difference for our customers and one another."

PlanetBids champions a culture built around five core values that guide how the team works, grows, and supports one another:

One of the largest IPOs in history comes onchain as SpaceX begins trading on day one

Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial